SCHEMBL8783501

SCHEMBL8783501

Cc1nc2cc3c(cc2c(=O)n1COC(=O)C(C)(C)C)[C@H](N(C)c1cccc(C(=O)Oc2c(F)c(F)c(F)c(F)c2F)c1F)CC3

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8784818 0.90 ACHE (0.31)
SCHEMBL8783914 0.88 EIF4EBP1 (0.30)
SCHEMBL8783284 0.86 KMT2A (0.36) KMT2A
SCHEMBL9201272 0.85 CYP3A4 (0.33) KMT2A
SCHEMBL9261159 0.84 EIF4EBP1 (0.32) KMT2A
SCHEMBL8784205 0.83 NAMPT (0.32)
SCHEMBL9209600 0.82 KDM4E (0.31) KMT2A
SCHEMBL9261164 0.80 EIF4EBP1 (0.33) KMT2A
SCHEMBL8784371 0.79 EIF4EBP1 (0.31) KMT2A
SCHEMBL8783765 0.78 KMT2A (0.30) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758328-A1 ANTI-CANCER COMPOUNDS CONTAINING CYCLOPENTAQUINAZOLINE RING BTG INTERNATIONAL LIMITED (GB) 1997-02-19 EP disclosed
WO-1995030673-A1 ANTI-CANCER COMPOUNDS CONTAINING CYCLOPENTAQUINAZOLINE RING BRITISH TECHNOLOGY GROUP LIMITED (GB) 1995-11-16 WO disclosed